Institution Directory

Clinical trials at Beth Israel Deaconess Medical Center

Sites in Boston, MA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 10:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

622

Shown on this page

Current sort

Stored official records

Conditions: Esophagogastric Cancer, Gastroesophageal Junction Adenocarcinoma
Interventions: Carboplatin, FOLFOX/ nal-IRI, Paclitaxel, Proton Radiation Therapy; Drug · Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 3
States / cities: Boston, Massachusetts • Newton, Massachusetts

Conditions: Lung Cancer
Interventions: Near Infrared Imaging; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2029
U.S. locations: 4
States / cities: Boston, Massachusetts

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Interventions: Biospecimen Collection, Carboplatin, Cyclophosphamide, Docetaxel, Doxorubicin, Paclitaxel, Pembrolizumab, Quality-of-Life Assessment, Questionnaire Administration, Surgical Procedure; Procedure · Drug · Biological + 1 more
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 955
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 654 more

Conditions: Non-small Cell Lung Cancer
Interventions: Telisotuzumab vedotin; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 56
States / cities: Mobile, Alabama • Phoenix, Arizona • Springdale, Arkansas + 49 more

Conditions: B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL
Interventions: ABL001, Blinatumomab, Dasatinib, Prednisone; Drug
Lead sponsor: Marlise Luskin, MD; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 4
States / cities: Chicago, Illinois • Boston, Massachusetts • Buffalo, New York

Conditions: Clinical High Risk, Conversion, Psychosis, Remission
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 12 Years to 30 Years
Enrollment: 2,617 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 17
States / cities: Irvine, California • Los Angeles, California • San Diego, California + 13 more

Conditions: Adipose Tissue, Adipose Tissue, Brown, Obesity
Interventions: Blood sample for DNA analysis, Blood sampling, Fat biopsy; Genetic · Diagnostic Test · Procedure
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart Transplant
Interventions: OCS Heart; Device
Lead sponsor: TransMedics; Industry
Eligibility: Not listed
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 37
States / cities: Phoenix, Arizona • La Jolla, California • Palo Alto, California + 27 more

Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Prostate Disease, Prostate Hyperplasia, Prostate Hypertrophy, Prostate Pain, Urinary Obstruction, Urinary Tract Disease
Interventions: Finasteride; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 50 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Distal Radius Fracture, Hip Fractures, Osteoporosis
Interventions: Reference Point Indentation; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 50 Years to 100 Years
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Mild Cognitive Impairment (MCI)
Interventions: Cognitive behavioral therapy for insomnia (CBT-I), Transcranial Magnetic Stimulation (TMS) therapy; Behavioral · Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gastric Emptying, Pregnancy
Interventions: Sports drink, Water; Dietary Supplement
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

About this Beth Israel Deaconess Medical Center institution page

What this page lists: ClinicalTrials.gov records that list Beth Israel Deaconess Medical Center in Boston, MA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Beth Israel Deaconess Medical Center

Filter and sort this campus

Stored official records

Folfox+Irinotecan+Chemort In Esophageal Cancer

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

AMP SCZ® Observational Study: PREDICT-DPACC

The Physiology of Human Brown Adipose Tissue

US National OCS Heart Perfusion (OHP) Registry

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

Treating Insomnia in Mild Cognitive Impairment

Gastric Emptying of Water and Sports Drink in Labor

About this Beth Israel Deaconess Medical Center institution page